Is there a hotter sector in medical devices today than neuromodulation/neurostimulation? Just a year after Boston Scientific leapt into the market by paying a huge amount of money--$740 million not counting earn-outs--for Advanced Bionics, St. Jude Medical tops that with its recently announced $1.3 billion deal for neuromodulation leader Advanced Neuromodulation Systems. (ANS). The acquisition offers St. Jude an additional growth platform outside its existing product offerings in cardiac rhythm management (particularly ICDs), atrial fibrillation, and cardiology.
Is there a hotter sector in medical devices today than
neuromodulation/neurostimulation? Just a year after Boston
Scientific Corp. leapt into the market by
paying a huge amount of money--$740 million not counting
earn-outs--for Advanced Bionics Inc.[See Deal], St.
Jude Medical Inc. tops that with its
recently announced $1.3 billion deal for neuromodulation leader
Advanced Neuromodulation Systems Inc.
(ANS). [See Deal]
In a conference call with analysts the day after the transaction was announced, St. Jude officials highlighted several reasons for...
